Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :28083930
Publication Date : //

Functional and structural characterization of four mouse monoclonal antibodies to complement C3 with potential therapeutic and diagnostic applications.


C3 is the central component of the complement system. Upon activation, C3 sequentially generates various proteolytic fragments, C3a, C3b, iC3b, C3dg, each of them exposing novel surfaces, which are sites of interaction with other proteins. C3 and its fragments are therapeutic targets and markers of complement activation. We report the structural and functional characterization of four monoclonal antibodies (mAbs) generated by immunizing C3-deficient mice with a mixture of human C3b, iC3b and C3dg fragments, and discuss their potential applications. This collection includes three mAbs interacting with native C3 and inhibiting AP complement activation; two of them by blocking the cleavage of C3 by the AP C3-converase and one by impeding formation of the AP C3-convertase. The interaction sites of these mAbs in the target molecules were determined by resolving the structures of Fab fragments bound to C3b and/or iC3b using electron microscopy. A fourth mAb specifically recognizes the iC3b, C3dg, and C3d fragments. It binds to an evolutionary-conserved neoepitope generated after C3b cleavage by FI, detecting iC3b/C3dg deposition over opsonized surfaces by flow cytometry and immunohistochemistry in human and other species. Because well-characterized anti-complement mAbs are uncommon, the mAbs reported here may offer interesting therapeutic and diagnostic opportunities.

Authors : Subías Hidalgo Marta , Yébenes Hugo , Rodríguez-Gallego César , Martín-Ambrosio Adrián , Domínguez Mercedes , Tortajada Agustin , Rodríguez de Córdoba Santiago , Llorca Oscar ,

Related products :

Catalog number Product name Quantity
FDA902 FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ
FDA902b FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replacing
1872 FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replacing
FDA902 FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replaced
FMO901-2 Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs_45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed
FMO901-1 Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 15 organs_45 cores, slide 1 of 2 tissue arrays; ihc Anti-Actin confirmed
1892 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases_45 cores, 2 slides set, replacing FRA901
FDA902-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases_45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed
FDA901-1 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide one); ihc Anti-Actin confirmed
FDA901-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide two); ihc Anti-Actin confirmed
FRA901a Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases_45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed
1862 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases_45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2
1861 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases_45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1
FDA902b-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases_45 cores, slide 2 of 2 tissue arrays, replacing FDA902-2; ihc Anti-Actin confirmed
FRA901a-2 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases_45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c
FRA901a-1 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases_45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c
FDA901 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.; ih
1871 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides, rep
FDA902a FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides, rep
SCH-MCA507 MOUSE ANTI HUMAN COMPLEMENT FACTOR I, Product Type Monoclonal Antibody, Specificity COMPLEMENT FACTOR I, Target Species Human, Host Mouse, Format S_N, Isotypes IgG1, Applications E, IP, R, WB, 5 ml
MCA507 MOUSE ANTI HUMAN COMPLEMENT FACTOR I, Product Type Monoclonal Antibody, Specificity COMPLEMENT FACTOR I, Target Species Human, Host Mouse, Format S_N, Isotypes IgG1, Applications E, IP, R, WB, 5 ml
SCH-MCA509G MOUSE ANTI HUMAN COMPLEMENT FACTOR H, Product Type Monoclonal Antibody, Specificity COMPLEMENT FACTOR H, Target Species Human, Host Mouse, Format Purified, Isotypes IgG1, Applications E, IP, WB 0.2 mg
MCA2614 MOUSE ANTI HUMAN COMPLEMENT FACTOR H, Product Type Monoclonal Antibody, Specificity COMPLEMENT FACTOR H, Target Species Human, Host Mouse, Format Purified, Isotypes IgG1, Applications C, E, F, 0.1 mg
SCH-MCA508G MOUSE ANTI HUMAN COMPLEMENT FACTOR H, Product Type Monoclonal Antibody, Specificity COMPLEMENT FACTOR H, Target Species Human, Host Mouse, Format Purified, Isotypes IgG1, Applications E, IP, R, 0.2 mg
MCA509G MOUSE ANTI HUMAN COMPLEMENT FACTOR H, Product Type Monoclonal Antibody, Specificity COMPLEMENT FACTOR H, Target Species Human, Host Mouse, Format Purified, Isotypes IgG1, Applications E, IP, WB 0.2 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur